Former AstraZeneca exec takes over as CEO of $660M Fort Myers lab firm

NeoGenomics announced a deal to acquire Pathline in March.
NeoGenomics announced a deal to acquire Pathline in March.
Courtesy Image
  • Charlotte–Lee–Collier
  • Share

Fort Myers-based cancer-focused genetic testing services firm NeoGenomics made two key announcements earlier in April. It completed a CEO succession plan announced in January and closed an acquisition to buy a New Jersey lab firm. 

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • March 19, 2026
Water slides, bowling, go-karts and lots more coming to Lakewood Ranch
  • March 19, 2026
Downtown Sarasota apartment project would replace breakfast restaurant
  • March 19, 2026
Tampa eye care nonprofit closes on property for new $16M center
  • March 18, 2026
Global aeronautics manufacturer expands Manatee facility

Sponsored Content